Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial.

Ann Oncol · 2010 · PMC2962260 · PMID 20439345

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

close to being statistically significantno p-value reported

These two evaluations showed a response rate between the two arms which was close to being statistically significant.

also in 228 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.